Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
6 Feb 2004
UCB - Acquisition of innovative treatments in allergy
Read More
4 Feb 2004
UCB Group - Provisional Results for 2003: Increase in Net Profit.
Read More
18 Dec 2003
UCB: Confidence in the future - Significant Programmes for R&D and Investment for the Year 2004.
Read More
22 Oct 2003
UCB: Third quarter Zyrtec sales in the US
Read More
30 Sep 2003
UCB : Closing of the sale of Methylamines & Derivatives Activities
Read More
24 Sep 2003
UCB Pharma enters European licensing agreement with Watson
Read More
22 Sep 2003
UCB : New Director-General of the Pharma Sector
Read More
16 Sep 2003
UCB invests in new production unit of Radcure monomers
Read More
16 Aug 2003
UCB : Sale of Methylamines & Derivatives Activities
Read More
29 Jul 2003
UCB Group : 2003 first half-year result
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
101
Page
102
Page
103
Page
104
Page
105
Page
106
Page
107
Current page
108
Page
109
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss